Publications by authors named "A Haarmann"

Aim: To date, there are only a few studies analyzing health professionals' health literacy (HL). Mostly, the focus has been on personal rather than professional HL. To bridge this gap, a new concept and an associated survey instrument have been developed in a three-country consortium.

View Article and Find Full Text PDF

Professional health literacy among nurses in Germany: Results of a quantitative, cross-sectional survey Little is known about the professional health literacy (HL) of nurses, i.e., how well they are able to promote patients' HL.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on predictive markers for progression in people with progressive multiple sclerosis (pwPMS), specifically examining serum glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL).
  • Researchers analyzed data from 243 pwPMS participants, finding that high GFAP levels, especially in those with low NfL, were linked to increased disability progression risk over time.
  • The findings suggest that measuring GFAP in blood could be useful for identifying pwPPMS patients who are at a higher risk for disease progression, potentially aiding in more tailored treatment approaches.
View Article and Find Full Text PDF

Background: Neuromyelitis optica spectrum disorder (NMOSD) is a devastating inflammatory disease of the central nervous system that is often severely disabling from the outset. The lack of pathognomonic aquaporin 4 (AQP4) antibodies in seronegative NMOSD not only hinders early diagnosis, but also limits therapeutic options, in contrast to AQP4 antibody-positive NMOSD, where the therapeutic landscape has recently evolved massively.

Case Presentation: We report a 56-year-old woman with bilateral optic neuritis and longitudinally extensive myelitis as the index events of a seronegative NMOSD, who was successfully treated with inebilizumab.

View Article and Find Full Text PDF

Objectives: Detection and prediction of disability progression is a significant unmet need in people with progressive multiple sclerosis (PwPMS). Government and health agencies have deemed the use of patient-reported outcomes measurements (PROMs) in clinical practice and clinical trials a major strategic priority. Nevertheless, data documenting the clinical utility of PROMs in neurological diseases is scarce.

View Article and Find Full Text PDF